nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—Methylscopolamine bromide—Tiotropium—chronic obstructive pulmonary disease	0.531	1	CrCrCtD
Scopolamine—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.127	0.345	CbGbCtD
Scopolamine—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.081	0.22	CbGbCtD
Scopolamine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0705	0.192	CbGbCtD
Scopolamine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.065	0.177	CbGbCtD
Scopolamine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0125	0.0341	CbGbCtD
Scopolamine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0118	0.0322	CbGbCtD
Scopolamine—Disturbance in attention—Montelukast—chronic obstructive pulmonary disease	0.00084	0.00896	CcSEcCtD
Scopolamine—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.000792	0.00845	CcSEcCtD
Scopolamine—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.000676	0.00721	CcSEcCtD
Scopolamine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.000674	0.00718	CcSEcCtD
Scopolamine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.000644	0.00687	CcSEcCtD
Scopolamine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.000635	0.00677	CcSEcCtD
Scopolamine—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.000612	0.00653	CcSEcCtD
Scopolamine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000599	0.00639	CcSEcCtD
Scopolamine—Drug withdrawal syndrome—Prednisone—chronic obstructive pulmonary disease	0.000596	0.00636	CcSEcCtD
Scopolamine—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.00059	0.0063	CcSEcCtD
Scopolamine—Eczema—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00627	CcSEcCtD
Scopolamine—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.000577	0.00616	CcSEcCtD
Scopolamine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000575	0.00613	CcSEcCtD
Scopolamine—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.000566	0.00604	CcSEcCtD
Scopolamine—Thirst—Montelukast—chronic obstructive pulmonary disease	0.000555	0.00592	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000541	0.00577	CcSEcCtD
Scopolamine—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.00054	0.00576	CcSEcCtD
Scopolamine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000512	0.00546	CcSEcCtD
Scopolamine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000507	0.00541	CcSEcCtD
Scopolamine—Mydriasis—Prednisolone—chronic obstructive pulmonary disease	0.000504	0.00538	CcSEcCtD
Scopolamine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.000504	0.00538	CcSEcCtD
Scopolamine—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.000494	0.00527	CcSEcCtD
Scopolamine—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.000494	0.00527	CcSEcCtD
Scopolamine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00518	CcSEcCtD
Scopolamine—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.000459	0.00489	CcSEcCtD
Scopolamine—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.000456	0.00487	CcSEcCtD
Scopolamine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.000455	0.00485	CcSEcCtD
Scopolamine—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.000453	0.00483	CcSEcCtD
Scopolamine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00045	0.0048	CcSEcCtD
Scopolamine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000446	0.00476	CcSEcCtD
Scopolamine—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000445	0.00475	CcSEcCtD
Scopolamine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000438	0.00467	CcSEcCtD
Scopolamine—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000432	0.00461	CcSEcCtD
Scopolamine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00043	0.00459	CcSEcCtD
Scopolamine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000413	0.0044	CcSEcCtD
Scopolamine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000413	0.0044	CcSEcCtD
Scopolamine—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00439	CcSEcCtD
Scopolamine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00434	CcSEcCtD
Scopolamine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000405	0.00432	CcSEcCtD
Scopolamine—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.000404	0.00431	CcSEcCtD
Scopolamine—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.000404	0.00431	CcSEcCtD
Scopolamine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.0004	0.00426	CcSEcCtD
Scopolamine—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.000396	0.00422	CcSEcCtD
Scopolamine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00418	CcSEcCtD
Scopolamine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000392	0.00418	CcSEcCtD
Scopolamine—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.00407	CcSEcCtD
Scopolamine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00404	CcSEcCtD
Scopolamine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00401	CcSEcCtD
Scopolamine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000375	0.004	CcSEcCtD
Scopolamine—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00037	0.00395	CcSEcCtD
Scopolamine—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00037	0.00395	CcSEcCtD
Scopolamine—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.00393	CcSEcCtD
Scopolamine—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000368	0.00393	CcSEcCtD
Scopolamine—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000366	0.0039	CcSEcCtD
Scopolamine—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.0039	CcSEcCtD
Scopolamine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000363	0.00388	CcSEcCtD
Scopolamine—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000363	0.00387	CcSEcCtD
Scopolamine—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000361	0.00385	CcSEcCtD
Scopolamine—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00383	CcSEcCtD
Scopolamine—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00383	CcSEcCtD
Scopolamine—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000358	0.00382	CcSEcCtD
Scopolamine—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00373	CcSEcCtD
Scopolamine—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00371	CcSEcCtD
Scopolamine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000345	0.00368	CcSEcCtD
Scopolamine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00368	CcSEcCtD
Scopolamine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000341	0.00364	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00034	0.00363	CcSEcCtD
Scopolamine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00034	0.00362	CcSEcCtD
Scopolamine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000335	0.00357	CcSEcCtD
Scopolamine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00355	CcSEcCtD
Scopolamine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00355	CcSEcCtD
Scopolamine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000332	0.00354	CcSEcCtD
Scopolamine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000329	0.00351	CcSEcCtD
Scopolamine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000329	0.00351	CcSEcCtD
Scopolamine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000328	0.0035	CcSEcCtD
Scopolamine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000327	0.00349	CcSEcCtD
Scopolamine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00349	CcSEcCtD
Scopolamine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00348	CcSEcCtD
Scopolamine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00348	CcSEcCtD
Scopolamine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000325	0.00347	CcSEcCtD
Scopolamine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000322	0.00343	CcSEcCtD
Scopolamine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00032	0.00342	CcSEcCtD
Scopolamine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00032	0.00341	CcSEcCtD
Scopolamine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000319	0.0034	CcSEcCtD
Scopolamine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00336	CcSEcCtD
Scopolamine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00031	0.00331	CcSEcCtD
Scopolamine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00329	CcSEcCtD
Scopolamine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00324	CcSEcCtD
Scopolamine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00324	CcSEcCtD
Scopolamine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00318	CcSEcCtD
Scopolamine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00318	CcSEcCtD
Scopolamine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00318	CcSEcCtD
Scopolamine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00312	CcSEcCtD
Scopolamine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00306	CcSEcCtD
Scopolamine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.003	CcSEcCtD
Scopolamine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.00299	CcSEcCtD
Scopolamine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00294	CcSEcCtD
Scopolamine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000275	0.00294	CcSEcCtD
Scopolamine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000275	0.00294	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00293	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00293	CcSEcCtD
Scopolamine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00288	CcSEcCtD
Scopolamine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00288	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00287	CcSEcCtD
Scopolamine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000268	0.00285	CcSEcCtD
Scopolamine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00283	CcSEcCtD
Scopolamine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00283	CcSEcCtD
Scopolamine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00277	CcSEcCtD
Scopolamine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00277	CcSEcCtD
Scopolamine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.00277	CcSEcCtD
Scopolamine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00277	CcSEcCtD
Scopolamine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00276	CcSEcCtD
Scopolamine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00276	CcSEcCtD
Scopolamine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00275	CcSEcCtD
Scopolamine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00275	CcSEcCtD
Scopolamine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00275	CcSEcCtD
Scopolamine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00272	CcSEcCtD
Scopolamine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00271	CcSEcCtD
Scopolamine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00269	CcSEcCtD
Scopolamine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00267	CcSEcCtD
Scopolamine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00264	CcSEcCtD
Scopolamine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00264	CcSEcCtD
Scopolamine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000246	0.00263	CcSEcCtD
Scopolamine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00262	CcSEcCtD
Scopolamine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.0026	CcSEcCtD
Scopolamine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00259	CcSEcCtD
Scopolamine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00258	CcSEcCtD
Scopolamine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00251	CcSEcCtD
Scopolamine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00251	CcSEcCtD
Scopolamine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00249	CcSEcCtD
Scopolamine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000232	0.00248	CcSEcCtD
Scopolamine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00246	CcSEcCtD
Scopolamine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00023	0.00246	CcSEcCtD
Scopolamine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00244	CcSEcCtD
Scopolamine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00244	CcSEcCtD
Scopolamine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00242	CcSEcCtD
Scopolamine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00242	CcSEcCtD
Scopolamine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00242	CcSEcCtD
Scopolamine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00242	CcSEcCtD
Scopolamine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00241	CcSEcCtD
Scopolamine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00239	CcSEcCtD
Scopolamine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00237	CcSEcCtD
Scopolamine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00237	CcSEcCtD
Scopolamine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000221	0.00236	CcSEcCtD
Scopolamine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00022	0.00234	CcSEcCtD
Scopolamine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000219	0.00234	CcSEcCtD
Scopolamine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00233	CcSEcCtD
Scopolamine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00233	CcSEcCtD
Scopolamine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00233	CcSEcCtD
Scopolamine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000218	0.00233	CcSEcCtD
Scopolamine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000217	0.00232	CcSEcCtD
Scopolamine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.0023	CcSEcCtD
Scopolamine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00228	CcSEcCtD
Scopolamine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00228	CcSEcCtD
Scopolamine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00223	CcSEcCtD
Scopolamine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00223	CcSEcCtD
Scopolamine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00223	CcSEcCtD
Scopolamine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00223	CcSEcCtD
Scopolamine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000209	0.00223	CcSEcCtD
Scopolamine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000207	0.00221	CcSEcCtD
Scopolamine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000207	0.00221	CcSEcCtD
Scopolamine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000207	0.00221	CcSEcCtD
Scopolamine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.00221	CcSEcCtD
Scopolamine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.0022	CcSEcCtD
Scopolamine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000206	0.00219	CcSEcCtD
Scopolamine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.00219	CcSEcCtD
Scopolamine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00219	CcSEcCtD
Scopolamine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00219	CcSEcCtD
Scopolamine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00216	CcSEcCtD
Scopolamine—Atropine—CYP1A2—chronic obstructive pulmonary disease	0.0002	1	CrCbGaD
Scopolamine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00211	CcSEcCtD
Scopolamine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00211	CcSEcCtD
Scopolamine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.00208	CcSEcCtD
Scopolamine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00208	CcSEcCtD
Scopolamine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00207	CcSEcCtD
Scopolamine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.00203	CcSEcCtD
Scopolamine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00019	0.00203	CcSEcCtD
Scopolamine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000187	0.002	CcSEcCtD
Scopolamine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.002	CcSEcCtD
Scopolamine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000187	0.002	CcSEcCtD
Scopolamine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000186	0.00199	CcSEcCtD
Scopolamine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00196	CcSEcCtD
Scopolamine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00192	CcSEcCtD
Scopolamine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00191	CcSEcCtD
Scopolamine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00189	CcSEcCtD
Scopolamine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.00188	CcSEcCtD
Scopolamine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00187	CcSEcCtD
Scopolamine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00187	CcSEcCtD
Scopolamine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00183	CcSEcCtD
Scopolamine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.0018	CcSEcCtD
Scopolamine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000168	0.0018	CcSEcCtD
Scopolamine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00178	CcSEcCtD
Scopolamine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00178	CcSEcCtD
Scopolamine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00178	CcSEcCtD
Scopolamine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00178	CcSEcCtD
Scopolamine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00177	CcSEcCtD
Scopolamine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00177	CcSEcCtD
Scopolamine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00177	CcSEcCtD
Scopolamine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00176	CcSEcCtD
Scopolamine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00176	CcSEcCtD
Scopolamine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00175	CcSEcCtD
Scopolamine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00174	CcSEcCtD
Scopolamine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00173	CcSEcCtD
Scopolamine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.0017	CcSEcCtD
Scopolamine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.00168	CcSEcCtD
Scopolamine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00168	CcSEcCtD
Scopolamine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00168	CcSEcCtD
Scopolamine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00168	CcSEcCtD
Scopolamine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00168	CcSEcCtD
Scopolamine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00167	CcSEcCtD
Scopolamine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00164	CcSEcCtD
Scopolamine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00159	CcSEcCtD
Scopolamine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00159	CcSEcCtD
Scopolamine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00156	CcSEcCtD
Scopolamine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.00153	CcSEcCtD
Scopolamine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00149	CcSEcCtD
Scopolamine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00148	CcSEcCtD
Scopolamine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00146	CcSEcCtD
Scopolamine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00145	CcSEcCtD
Scopolamine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000131	0.0014	CcSEcCtD
Scopolamine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00137	CcSEcCtD
Scopolamine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00136	CcSEcCtD
Scopolamine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00131	CcSEcCtD
Scopolamine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00128	CcSEcCtD
Scopolamine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00126	CcSEcCtD
Scopolamine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00125	CcSEcCtD
Scopolamine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00122	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00115	CcSEcCtD
Scopolamine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00111	CcSEcCtD
Scopolamine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00109	CcSEcCtD
Scopolamine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00109	CcSEcCtD
Scopolamine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00108	CcSEcCtD
Scopolamine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00108	CcSEcCtD
Scopolamine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.49e-05	0.00101	CcSEcCtD
Scopolamine—Rash—Prednisolone—chronic obstructive pulmonary disease	9.05e-05	0.000965	CcSEcCtD
Scopolamine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.04e-05	0.000964	CcSEcCtD
Scopolamine—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.99e-05	0.000959	CcSEcCtD
Scopolamine—Headache—Prednisolone—chronic obstructive pulmonary disease	8.99e-05	0.000959	CcSEcCtD
Scopolamine—Constipation—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000951	CcSEcCtD
Scopolamine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.59e-05	0.000917	CcSEcCtD
Scopolamine—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.52e-05	0.000909	CcSEcCtD
Scopolamine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.000879	CcSEcCtD
Scopolamine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.000879	CcSEcCtD
Scopolamine—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.48e-05	0.000798	CcSEcCtD
Scopolamine—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.000787	CcSEcCtD
Scopolamine—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.9e-05	0.000735	CcSEcCtD
Scopolamine—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.63e-05	0.000707	CcSEcCtD
Scopolamine—Rash—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000701	CcSEcCtD
Scopolamine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000701	CcSEcCtD
Scopolamine—Headache—Prednisone—chronic obstructive pulmonary disease	6.53e-05	0.000697	CcSEcCtD
Scopolamine—Nausea—Prednisone—chronic obstructive pulmonary disease	6.19e-05	0.000661	CcSEcCtD
Scopolamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.62e-05	0.00211	CbGpPWpGaD
Scopolamine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.62e-05	0.0021	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.61e-05	0.0021	CbGpPWpGaD
Scopolamine—CHRM4—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.6e-05	0.00208	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.6e-05	0.00208	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.59e-05	0.00206	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.59e-05	0.00206	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.00206	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.57e-05	0.00204	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.57e-05	0.00204	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.57e-05	0.00204	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	1.57e-05	0.00203	CbGpPWpGaD
Scopolamine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	1.53e-05	0.00199	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.52e-05	0.00197	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.51e-05	0.00196	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.51e-05	0.00196	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.5e-05	0.00195	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.49e-05	0.00194	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	1.48e-05	0.00192	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	1.44e-05	0.00188	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	1.42e-05	0.00184	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.39e-05	0.0018	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.38e-05	0.0018	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.37e-05	0.00178	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.37e-05	0.00178	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.37e-05	0.00178	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.36e-05	0.00176	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.35e-05	0.00176	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.35e-05	0.00175	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.34e-05	0.00173	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	1.33e-05	0.00172	CbGpPWpGaD
Scopolamine—SI—Disease—TGFB1—chronic obstructive pulmonary disease	1.3e-05	0.00168	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.28e-05	0.00166	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.00165	CbGpPWpGaD
Scopolamine—SI—Disease—EGFR—chronic obstructive pulmonary disease	1.27e-05	0.00165	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	1.24e-05	0.00161	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	1.22e-05	0.00159	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.22e-05	0.00158	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.22e-05	0.00158	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	1.22e-05	0.00158	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.21e-05	0.00158	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.21e-05	0.00157	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.21e-05	0.00157	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.2e-05	0.00156	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.2e-05	0.00156	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.00156	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1.2e-05	0.00156	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.19e-05	0.00155	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.15e-05	0.0015	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.15e-05	0.0015	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	1.14e-05	0.00148	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.14e-05	0.00148	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.13e-05	0.00147	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.13e-05	0.00147	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.12e-05	0.00146	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.11e-05	0.00144	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.1e-05	0.00143	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.09e-05	0.00142	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.09e-05	0.00141	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.07e-05	0.00139	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.07e-05	0.00139	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.07e-05	0.00138	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.06e-05	0.00137	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.06e-05	0.00137	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.05e-05	0.00137	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.04e-05	0.00136	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.03e-05	0.00134	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.03e-05	0.00134	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.01e-05	0.00132	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.86e-06	0.00128	CbGpPWpGaD
Scopolamine—SI—Disease—IL6—chronic obstructive pulmonary disease	9.77e-06	0.00127	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.7e-06	0.00126	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.7e-06	0.00126	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.69e-06	0.00126	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.29e-06	0.00121	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.28e-06	0.00121	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	9.24e-06	0.0012	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.2e-06	0.0012	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.86e-06	0.00115	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.81e-06	0.00114	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	8.58e-06	0.00111	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	8.55e-06	0.00111	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.49e-06	0.0011	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	8.47e-06	0.0011	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	8.47e-06	0.0011	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	8.44e-06	0.0011	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	8.31e-06	0.00108	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.11e-06	0.00105	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.1e-06	0.00105	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.09e-06	0.00105	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.05e-06	0.00105	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.01e-06	0.00104	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	7.88e-06	0.00102	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.71e-06	0.001	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.65e-06	0.000993	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.62e-06	0.00099	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.55e-06	0.00098	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	7.5e-06	0.000975	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.32e-06	0.000951	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.09e-06	0.000921	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.94e-06	0.000902	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.92e-06	0.000899	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	6.87e-06	0.000892	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.85e-06	0.00089	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.83e-06	0.000888	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.81e-06	0.000885	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.79e-06	0.000882	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.78e-06	0.000881	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.74e-06	0.000876	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	6.7e-06	0.000871	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.59e-06	0.000856	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	6.54e-06	0.00085	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.54e-06	0.000849	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	6.53e-06	0.000849	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.52e-06	0.000847	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	6.51e-06	0.000846	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	6.51e-06	0.000846	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	6.49e-06	0.000843	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.45e-06	0.000838	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	6.45e-06	0.000838	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.31e-06	0.00082	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.28e-06	0.000816	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.2e-06	0.000806	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.18e-06	0.000803	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.12e-06	0.000796	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	6.12e-06	0.000794	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.08e-06	0.00079	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	6.01e-06	0.00078	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.98e-06	0.000776	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.96e-06	0.000774	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.9e-06	0.000766	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.89e-06	0.000765	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.83e-06	0.000757	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.64e-06	0.000732	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	5.61e-06	0.000729	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.48e-06	0.000711	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.44e-06	0.000706	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.43e-06	0.000705	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.41e-06	0.000703	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.36e-06	0.000696	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.24e-06	0.000681	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.21e-06	0.000676	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.97e-06	0.000646	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.94e-06	0.000642	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.94e-06	0.000642	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.78e-06	0.000621	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.77e-06	0.000619	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.76e-06	0.000619	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.76e-06	0.000618	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.73e-06	0.000615	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.72e-06	0.000613	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.7e-06	0.000611	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.64e-06	0.000602	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.55e-06	0.000592	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.44e-06	0.000577	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.43e-06	0.000575	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.42e-06	0.000574	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.39e-06	0.00057	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.32e-06	0.000561	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.3e-06	0.000559	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.25e-06	0.000552	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.23e-06	0.00055	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.1e-06	0.000533	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.09e-06	0.000532	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.09e-06	0.000531	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.05e-06	0.000526	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.88e-06	0.000504	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.77e-06	0.00049	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.69e-06	0.00048	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.68e-06	0.000478	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.67e-06	0.000476	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.65e-06	0.000475	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.65e-06	0.000474	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.63e-06	0.000472	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.62e-06	0.00047	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.58e-06	0.000464	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.48e-06	0.000452	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.47e-06	0.000451	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.35e-06	0.000436	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.34e-06	0.000434	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.33e-06	0.000433	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.32e-06	0.000432	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.32e-06	0.000431	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.31e-06	0.00043	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.31e-06	0.00043	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.29e-06	0.000427	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.21e-06	0.000417	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.2e-06	0.000415	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.17e-06	0.000412	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.17e-06	0.000411	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.98e-06	0.000387	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.98e-06	0.000387	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.97e-06	0.000386	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.94e-06	0.000382	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.94e-06	0.000382	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.94e-06	0.000382	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.81e-06	0.000365	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.79e-06	0.000363	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	2.78e-06	0.000362	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.74e-06	0.000356	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.68e-06	0.000348	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	2.66e-06	0.000346	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.66e-06	0.000345	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.6e-06	0.000337	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.54e-06	0.000331	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.45e-06	0.000318	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.44e-06	0.000317	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.42e-06	0.000314	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.39e-06	0.00031	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.34e-06	0.000304	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.33e-06	0.000303	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.31e-06	0.0003	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.28e-06	0.000297	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.23e-06	0.00029	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.23e-06	0.000289	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.2e-06	0.000286	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.19e-06	0.000284	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.15e-06	0.000279	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.1e-06	0.000272	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.06e-06	0.000267	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.98e-06	0.000257	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.97e-06	0.000257	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.96e-06	0.000254	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.88e-06	0.000245	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.88e-06	0.000244	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.86e-06	0.000242	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.8e-06	0.000234	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.79e-06	0.000233	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.79e-06	0.000232	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.77e-06	0.00023	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.77e-06	0.000229	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.73e-06	0.000224	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.69e-06	0.000219	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.65e-06	0.000214	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.61e-06	0.000209	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.6e-06	0.000208	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.59e-06	0.000206	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.58e-06	0.000205	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.48e-06	0.000192	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.47e-06	0.000191	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.46e-06	0.000189	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.45e-06	0.000188	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.44e-06	0.000187	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.43e-06	0.000186	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.22e-06	0.000158	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.21e-06	0.000157	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.2e-06	0.000156	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.11e-06	0.000145	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.11e-06	0.000144	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.1e-06	0.000143	CbGpPWpGaD
